These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
938 related articles for article (PubMed ID: 26117331)
21. Mechanisms of activation of the transcription factor Nrf2 by redox stressors, nutrient cues, and energy status and the pathways through which it attenuates degenerative disease. Tebay LE; Robertson H; Durant ST; Vitale SR; Penning TM; Dinkova-Kostova AT; Hayes JD Free Radic Biol Med; 2015 Nov; 88(Pt B):108-146. PubMed ID: 26122708 [TBL] [Abstract][Full Text] [Related]
22. The Keap1-Nrf2-antioxidant response element pathway: a review of its regulation by melatonin and the proteasome. Vriend J; Reiter RJ Mol Cell Endocrinol; 2015 Feb; 401():213-20. PubMed ID: 25528518 [TBL] [Abstract][Full Text] [Related]
23. A Naturally-Occurring Dominant-Negative Inhibitor of Keap1 Competitively against Its Negative Regulation of Nrf2. Qiu L; Wang M; Zhu Y; Xiang Y; Zhang Y Int J Mol Sci; 2018 Jul; 19(8):. PubMed ID: 30042301 [TBL] [Abstract][Full Text] [Related]
24. Characterizations of Three Major Cysteine Sensors of Keap1 in Stress Response. Saito R; Suzuki T; Hiramoto K; Asami S; Naganuma E; Suda H; Iso T; Yamamoto H; Morita M; Baird L; Furusawa Y; Negishi T; Ichinose M; Yamamoto M Mol Cell Biol; 2016 Jan; 36(2):271-84. PubMed ID: 26527616 [TBL] [Abstract][Full Text] [Related]
25. Activation of the Nrf2/ARE pathway via S-alkylation of cysteine 151 in the chemopreventive agent-sensor Keap1 protein by falcarindiol, a conjugated diacetylene compound. Ohnuma T; Nakayama S; Anan E; Nishiyama T; Ogura K; Hiratsuka A Toxicol Appl Pharmacol; 2010 Apr; 244(1):27-36. PubMed ID: 20026152 [TBL] [Abstract][Full Text] [Related]
26. TrxR1 as a potent regulator of the Nrf2-Keap1 response system. Cebula M; Schmidt EE; Arnér ES Antioxid Redox Signal; 2015 Oct; 23(10):823-53. PubMed ID: 26058897 [TBL] [Abstract][Full Text] [Related]
27. The keap1-nrf2 cellular defense pathway: mechanisms of regulation and role in protection against drug-induced toxicity. Copple IM; Goldring CE; Kitteringham NR; Park BK Handb Exp Pharmacol; 2010; (196):233-66. PubMed ID: 20020265 [TBL] [Abstract][Full Text] [Related]
28. Nrf2 protects against airway disorders. Cho HY; Kleeberger SR Toxicol Appl Pharmacol; 2010 Apr; 244(1):43-56. PubMed ID: 19646463 [TBL] [Abstract][Full Text] [Related]
29. The Molecular Mechanisms Regulating the KEAP1-NRF2 Pathway. Baird L; Yamamoto M Mol Cell Biol; 2020 Jun; 40(13):. PubMed ID: 32284348 [TBL] [Abstract][Full Text] [Related]
30. Alterations in the Nrf2-Keap1 signaling pathway and its downstream target genes in rat brain under stress. Djordjevic J; Djordjevic A; Adzic M; Mitic M; Lukic I; Radojcic MB Brain Res; 2015 Mar; 1602():20-31. PubMed ID: 25598205 [TBL] [Abstract][Full Text] [Related]
31. Regulation of the Nrf2-Keap1 antioxidant response by the ubiquitin proteasome system: an insight into cullin-ring ubiquitin ligases. Villeneuve NF; Lau A; Zhang DD Antioxid Redox Signal; 2010 Dec; 13(11):1699-712. PubMed ID: 20486766 [TBL] [Abstract][Full Text] [Related]
32. KEAP1-NRF2 signalling and autophagy in protection against oxidative and reductive proteotoxicity. Dodson M; Redmann M; Rajasekaran NS; Darley-Usmar V; Zhang J Biochem J; 2015 Aug; 469(3):347-55. PubMed ID: 26205490 [TBL] [Abstract][Full Text] [Related]
34. Signaling pathways activated by the phytochemical nordihydroguaiaretic acid contribute to a Keap1-independent regulation of Nrf2 stability: Role of glycogen synthase kinase-3. Rojo AI; Medina-Campos ON; Rada P; Zúñiga-Toalá A; López-Gazcón A; Espada S; Pedraza-Chaverri J; Cuadrado A Free Radic Biol Med; 2012 Jan; 52(2):473-87. PubMed ID: 22142471 [TBL] [Abstract][Full Text] [Related]
35. Keap1 controls postinduction repression of the Nrf2-mediated antioxidant response by escorting nuclear export of Nrf2. Sun Z; Zhang S; Chan JY; Zhang DD Mol Cell Biol; 2007 Sep; 27(18):6334-49. PubMed ID: 17636022 [TBL] [Abstract][Full Text] [Related]
36. A novel shogaol analog suppresses cancer cell invasion and inflammation, and displays cytoprotective effects through modulation of NF-κB and Nrf2-Keap1 signaling pathways. Gan FF; Ling H; Ang X; Reddy SA; Lee SS; Yang H; Tan SH; Hayes JD; Chui WK; Chew EH Toxicol Appl Pharmacol; 2013 Nov; 272(3):852-62. PubMed ID: 23899529 [TBL] [Abstract][Full Text] [Related]
37. The Keap1/Nrf2 pathway in health and disease: from the bench to the clinic. O'Connell MA; Hayes JD Biochem Soc Trans; 2015 Aug; 43(4):687-9. PubMed ID: 26551713 [TBL] [Abstract][Full Text] [Related]
38. Role of the Keap1-Nrf2 pathway in cancer. Leinonen HM; Kansanen E; Pölönen P; Heinäniemi M; Levonen AL Adv Cancer Res; 2014; 122():281-320. PubMed ID: 24974185 [TBL] [Abstract][Full Text] [Related]
39. Loss of Keap1 function activates Nrf2 and provides advantages for lung cancer cell growth. Ohta T; Iijima K; Miyamoto M; Nakahara I; Tanaka H; Ohtsuji M; Suzuki T; Kobayashi A; Yokota J; Sakiyama T; Shibata T; Yamamoto M; Hirohashi S Cancer Res; 2008 Mar; 68(5):1303-9. PubMed ID: 18316592 [TBL] [Abstract][Full Text] [Related]
40. Functional dissection of Nrf2-dependent phase II genes in vascular inflammation and endotoxic injury using Keap1 siRNA. Kim JH; Choi YK; Lee KS; Cho DH; Baek YY; Lee DK; Ha KS; Choe J; Won MH; Jeoung D; Lee H; Kwon YG; Kim YM Free Radic Biol Med; 2012 Aug; 53(3):629-40. PubMed ID: 22609006 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]